Xuwentai Liu
Overview
Explore the profile of Xuwentai Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Liu X, Wang M, Zhang X, Zhang Z, Xue L, et al.
Nano Lett
. 2024 Oct;
24(45):14531-14540.
PMID: 39405472
Immune checkpoint blockade (ICB) therapy has been approved for colorectal cancer (CRC). However, response rates are variable and often <50%. The low tumor immunogenicity and immunosuppressive tumor microenvironment (TME) jointly...
2.
Liu X, Wu Y, Li Y, Li K, Hou S, Ding M, et al.
J Zhejiang Univ Sci B
. 2023 Mar;
24(3):248-261.
PMID: 36916000
An effective therapeutic regimen for hepatic fibrosis requires a deep understanding of the pathogenesis mechanism. Hepatic fibrosis is characterized by activated hepatic stellate cells (aHSCs) with an excessive production of...
3.
Du J, Wang C, Chen Y, Zhong L, Liu X, Xue L, et al.
J Control Release
. 2022 Feb;
343:457-468.
PMID: 35124127
Tumor metastasis is directly correlated to poor prognosis and high mortality. Circulating tumor cells (CTCs) play a pivotal role in metastatic cascades, of which CTC clusters is highly metastatic compared...
4.
Wang C, Wang B, Hou S, Xue L, Kang Z, Du J, et al.
Eur J Med Chem
. 2019 Dec;
186:111907.
PMID: 31791642
No abstract available.
5.
Wang C, Wang B, Hou S, Xue L, Kang Z, Du J, et al.
Eur J Med Chem
. 2018 Dec;
163:787-803.
PMID: 30579121
Vitamin D receptor (VDR) is recognized as a potential target for the treatment of breast cancer which is the most common malignancy among women in the world. In this study,...